December 3rd & 4th, 2024
IN-PERSON | LILLE, FR
December 11th& 12th 2024
ONLINE MEETINGS
Dec 3rd & 4th, 2024
IN-PERSON | LILLE, FR
Dec 11th& 12th, 2024
ONLINE MEETINGS
Home » LEAP-BIO event
LEAP-BIO is a project funded by the Single Market Programme and aims to address the lack of intermediary services towards IP licensing and exploitation in key-target European regions/countries, such as Portugal, Spain, France, Italy and Wallonian region (Belgium).
The aim of the consortium is to develop an early-stage focused IP licensing intermediary service for biopharma SMEs and start-up companies in the target regions to contribute to drive the growth of the small and medium biopharma companies in such regions towards a more competitive European biopharma industry at a global level.
One major achievement of the project is the set-up of a sustainable IP licensing intermediary service of early-stage assets. Such newly developed tool consists in an AI-powered digital platform for matchmaking IP licensing interests, in association with the partnering platform on BioFIT to schedule one-on-one partnering meeting.
LEAP-BIO AI-powered digital platform:
novel IP Licensing intermediary services of early-stage assets in pharma and biotechs’
The brand-new LEAP-BIO Digital Platform has just been launched in late October 2023. Developed by INOVA with the LEAP-BIO consortium, the platform combines AI-powered digital tool and face-to-face partnering events on BioFIT. This will enable to promote licensing opportunities of early stage-assets from biopharma SMEs, start-up companies and TTOs towards Pharma & well-funded Biotechs, favorizing matchmaking processes.
To access the LEAP-BIO conference you must be registered at BioFIT
As a LEAP-BIO guest, you have a special discount to access BioFIT event.
Please request your coupon code to ccoisne@eurasante.com
LEAP-BIO is a partner in the Collaborative & Licensing Opportunities Presentations at BioFIT
LEAP-BIO project is currently seeking applicants, who own early-stage assets at the discovery or preclinical stage that match the licensing interests of big pharma and well-funded biotech companies.
Great opportunity for TTOs, universities, research institutes and start-ups is offered to showcase their promising early-stage assets in front of potential partners/ licensors in the pharmaceutical field, in order to entail licensing deals. Sciences.
APPLY
To apply to the Collaborative and Licensing Opportunity Presentations you must be registered to BioFIT.
To apply, the candidate must:
BE SELECTED
PITCH & BE AWARDED
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.